Stay updated on ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe recruitment status was updated to 'No longer looking for participants', indicating enrollment has closed. A new revision tag (v3.6.0) was added to replace the prior version (v3.5.5) in the record history.SummaryDifference0.5%

- Check16 days agoChange DetectedThe record history now shows the latest revision as v3.5.5, replacing the previous v3.5.4 entry. This reflects a metadata update to the page's history rather than a change to study information.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a new build of the page history. The change updates the version shown on the page without altering study data or content.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision label on the page changed from v3.5.2 to v3.5.3, indicating a new release of the record history UI. This update is administrative and does not alter trial data or text.SummaryDifference0.1%

- Check66 days agoChange DetectedNew revision v3.5.2 was added and v3.5.0 was removed from the record history.SummaryDifference0.1%

- Check95 days agoChange Detected- Revision v3.5.0 added to the Record History, and revision v3.4.3 removed.SummaryDifference0.1%

Stay in the know with updates to ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.